Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to better understand a new type of radiology test called positron emission tomography (PET) with carbon 11 methionine to determine which patients have a beneficial effect from anti-cancer therapy with the drug docetaxel.

Key facts

Study ID

NCT00139204

Run by

Dana-Farber Cancer Institute

People needed

20

Starts

2005-04-01

Expected to finish

2006-07-01

Last updated by the study team

2009-11-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Metastatic hormone-refractory prostate cancer patients who are planned to begin every 3-week docetaxel chemotherapy
• Progression after androgen deprivation therapy
• Serum testosterone < 50ng/ml
• 18 years of age or older

You may not qualify if…

• Prior taxane therapy

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.